A. Fauconnier, J.-B. Dubuisson, G. Bréart
{"title":"Symptômes douloureux de l'endométriose","authors":"A. Fauconnier,&nbsp;J.-B. Dubuisson,&nbsp;G. Bréart","doi":"10.1016/j.emcgo.2005.07.007","DOIUrl":null,"url":null,"abstract":"<div><p>Endomitosis is a benign chronic disease of the woman, responsible for the well-known chronic pelvic pain (CPP). However, the relationship between CPP and endomitosis remains unclear, primarily due to the high frequency of painful symptoms in women free of this disease, and to the frequency of asymptomatic endomitosis. In women with diagnosed endomitosis, the disease is responsible for CPP in less than 50% of the cases. A well documented relationship exists between severe dysmenorrhoea and endomitosis, probably causal. Severe dysmenorrhoea doesn't seem to be related to a specific type of lesion or to a particular location. Adherences may also be responsible for severe dysmenorrhoea. Regarding other painful symptoms, histological and pathophysiological evidences suggest the responsibility of deep sub-peritoneal endomitosis (DE) in their genesis. Such pain is probably related with compression or the infiltration of the pelvis-sub-peritoneal area by the DE lesions. Therefore, painful symptoms due to DE present some specific characteristics. They characterize a precise anatomically localized lesion (severe dyspareunia, painful defecation) or organ (functional urinary signs, digestive signs). Such symptoms may therefore be qualified as “localizating pains”. The precise semiotic analysis of the CPP characteristics is very useful for the diagnostic and therapeutic management of endomitosis-induced CPP. Hormone drug therapies generally show efficacy on all pains related to endomitosis lesions that comprise active glandular tissue. In some conditions with predominant fibrosis, adherences or cystic lesions, hormone therapies have no action on painful symptoms.</p></div>","PeriodicalId":100424,"journal":{"name":"EMC - Gynécologie-Obstétrique","volume":"2 4","pages":"Pages 297-311"},"PeriodicalIF":0.0000,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emcgo.2005.07.007","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMC - Gynécologie-Obstétrique","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1762614505000181","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

子宫内膜增多症是女性的一种良性慢性疾病,引起众所周知的慢性盆腔疼痛(CPP)。然而,CPP与子宫内膜增多症之间的关系尚不清楚,主要是由于没有这种疾病的女性疼痛症状的频率高,以及无症状子宫内膜增多症的频率高。在诊断为子宫内膜增多症的妇女中,该疾病导致CPP的病例不到50%。严重痛经和子宫内膜增多症之间有充分的文献记载,可能是因果关系。严重痛经似乎与特定类型的病变或特定部位无关。粘连也可能导致严重的痛经。对于其他疼痛症状,组织学和病理生理证据提示深层腹膜下内膜增多症(DE)在其发生中的责任。这种疼痛可能与DE病变压迫或浸润盆腔腹膜下区有关。因此,DE引起的疼痛症状呈现出一些特定的特征。它们表现为精确的解剖学上的局部病变(严重的性交困难,排便疼痛)或器官(功能性泌尿征象,消化征象)。因此,这种症状可称为“局部性疼痛”。CPP特征的精确符号学分析对子宫内膜病诱发的CPP的诊断和治疗管理非常有用。激素药物治疗通常对包括活跃腺体组织的子宫内膜增生病变相关的所有疼痛有效。在一些以纤维化、粘附或囊性病变为主的情况下,激素治疗对疼痛症状没有作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Symptômes douloureux de l'endométriose

Endomitosis is a benign chronic disease of the woman, responsible for the well-known chronic pelvic pain (CPP). However, the relationship between CPP and endomitosis remains unclear, primarily due to the high frequency of painful symptoms in women free of this disease, and to the frequency of asymptomatic endomitosis. In women with diagnosed endomitosis, the disease is responsible for CPP in less than 50% of the cases. A well documented relationship exists between severe dysmenorrhoea and endomitosis, probably causal. Severe dysmenorrhoea doesn't seem to be related to a specific type of lesion or to a particular location. Adherences may also be responsible for severe dysmenorrhoea. Regarding other painful symptoms, histological and pathophysiological evidences suggest the responsibility of deep sub-peritoneal endomitosis (DE) in their genesis. Such pain is probably related with compression or the infiltration of the pelvis-sub-peritoneal area by the DE lesions. Therefore, painful symptoms due to DE present some specific characteristics. They characterize a precise anatomically localized lesion (severe dyspareunia, painful defecation) or organ (functional urinary signs, digestive signs). Such symptoms may therefore be qualified as “localizating pains”. The precise semiotic analysis of the CPP characteristics is very useful for the diagnostic and therapeutic management of endomitosis-induced CPP. Hormone drug therapies generally show efficacy on all pains related to endomitosis lesions that comprise active glandular tissue. In some conditions with predominant fibrosis, adherences or cystic lesions, hormone therapies have no action on painful symptoms.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信